Literature DB >> 5958716

Rifampicin: a new orally active rifamycin.

N Maggi, C R Pasqualucci, R Ballotta, P Sensi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5958716     DOI： 10.1159/000220462

Source DB:  PubMed          Journal:  Chemotherapy        ISSN： 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  44 in total

1.  Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients.

Authors:  Andreas H Diacon; Rodney Dawson; Madeleine Hanekom; Kim Narunsky; Stefan J Maritz; Amour Venter; Peter R Donald; Christo van Niekerk; Karl Whitney; Doris J Rouse; Martino W Laurenzi; Ann M Ginsberg; Melvin K Spigelman
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

2.  History of spine surgery for tuberculous spondylodiscitis.

Authors:  S Rajasekaran; R M Kanna; A P Shetty
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

Review 3.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

4.  Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic.

Authors:  S J Andersen; S Quan; B Gowan; E R Dabbs
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

Authors:  S Takai; K Takeda; Y Nakano; T Karasawa; J Furugoori; Y Sasaki; S Tsubaki; T Higuchi; T Anzai; R Wada; M Kamada
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

6.  Rifamycins: modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chain.

Authors:  B Moss; E N Rosenblum; P M Grimley; S J Mims
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

7.  Relationships between bactericidal effect and inhibition of ribonucleic acid nucleotidyltransferase by rifampicin in Escherichia coli K-12.

Authors:  G Lancini; R Pallanza; L G Silvestri
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

8.  Growth of bacteriophage f2 in E. coli treated with rifampicin.

Authors:  H P Fromageot; N D Zinder
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

Review 9.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

10.  Interaction of intraleukocytic bacteria and antibiotics.

Authors:  G L Mandell
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.